MACKENZIE SCHRINEL: Open Payments
NPI 1053936740 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$962 in 53 payments from 13 companies in 2025. Trend: 2023 $1,279 · 2024 $1,670 · 2025 $962
Food & beverage: $962
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $340 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $206 |
| Ardelyx, Inc. | 3 | $68 |
| GENZYME CORPORATION | 3 | $58 |
| Intercept Pharmaceuticals, Inc. | 2 | $47 |
| QOL Medical, LLC | 2 | $42 |
| Ferring Pharmaceuticals Inc. | 1 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Organon LLC | 1 | $30 |
Products named: SKYRIZI, EOHILIA, ENTYVIO, RINVOQ, IBSRELA, CREON, DUPIXENT, OCALIVA.
Industry payments across OH — which companies pay providers there.
